From July 1, 2023 to September 30, 2023, the company has repurchased 5,851,132 shares, representing 0.31% for CNY 69.76 million. With this, the company has completed the repurchase of 46,513,711 shares, representing 2.44% for CNY 564.25 million under the buyback announced on December 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.16 CNY | +1.46% | +3.46% | +5.87% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.87% | 3.4B | |
+31.51% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.15% | 239B | |
+10.11% | 210B | |
-7.16% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- 600380 Stock
- News Joincare Pharmaceutical Group Industry Co.,Ltd.
- Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.